Topic List : Cancer
Chemotherapy declines for breast cancer
Chemotherapy use for early stage breast cancer declined from 2013 to 2015, possibly due to a preference for less toxic treatments, according to researchers at Stanford and the University of Michigan.
Second ‘don’t eat me’ signal found on cancer
CD47 is an important inhibitor of cancer-killing immune cells called macrophages. Now Stanford researchers have identified another, similar way to activate macrophages to destroy cancer cells.
Possible new cell therapy for leukemia
Instead of targeting a molecule called CD19 on the surface of the cancer cells, the new therapy targets a molecule called CD22.
Distinguishing features of high-value care
Two novel Stanford studies have uncovered attributes of high-quality, low-cost care for cancer and primary care patients.
Cancer research funds awarded
Maximilian Diehn, Sanjiv “Sam” Gambhir, Ash Alizadeh and Young-Jun Jeon will work on “dream teams” aiming to improve detection of cancer.
Center to support cancer immunotherapy
Stanford is one of four institutions to receive National Cancer Institute funding to analyze patients’ immune function and tumor profiles as part of a public-private partnership to accelerate cancer therapies.
Caregivers honor cancer patient
Minal Patel, a 26-year-old Packard Children’s patient, has always wanted to become a physician. When her cancer relapsed, her doctors and nurses planned a special way to recognize her goal.
Decoding tumor super-suppression
Stanford scientists have found an answer to one of cancer biology’s toughest and most important questions: How does the body suppress tumors?…
Brain tumor growth stopped
High-grade gliomas, a group of aggressive brain tumors, cease growing in mice if a signaling molecule called neuroligin-3 is absent or its activity is blocked with drugs, a Stanford team has shown.
Gift establishes cancer cell therapy center
Silicon Valley entrepreneur Jeffrey Rothschild and his wife, Marieke, have provided funding for a new venture at Stanford Medicine to test cancer cell therapies.